Publicacións en colaboración con investigadores/as de University of Innsbruck (8)

2022

  1. Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study

    Frontiers in Cardiovascular Medicine, Vol. 10

2020

  1. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  2. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

2016

  1. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II

    European Heart Journal, Vol. 37, Núm. 33, pp. 2591-2601

2015

  1. Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients

    BMC Cardiovascular Disorders, Vol. 15, Núm. 1

2012

  1. Concordance among pathologists in the second cardiac allograft rejection gene expression observational study (CARGO II)

    Transplantation, Vol. 94, Núm. 11, pp. 1172-1177

2006

  1. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - A large European trial

    American Journal of Transplantation, Vol. 6, Núm. 6, pp. 1387-1397

2005

  1. Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: A prospective European multicenter study

    Transplantation, Vol. 79, Núm. 1, pp. 65-71